SCHEMBL13065601

SCHEMBL13065601

CCN(CC)c1ccc2nc3c(C(=O)O)c(-c4ccc(F)cc4)c(=O)c(O)c-3oc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.43
MEN1 O00255 5/20 0.43
NPC1 O15118 1/20 0.43
POLB P06746 1/20 0.43
RAB9A P51151 1/20 0.43
ALDH1A1 P00352 6/20 0.41
KDM4E B2RXH2 4/20 0.41
HPGD P15428 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
ALOX15 P16050 2/20 0.41
HSD17B10 Q99714 2/20 0.41
SLC16A3 O15427 1/20 0.41
SLC16A1 P53985 1/20 0.41
SCP2 P22307 1/20 0.41
DHODH Q02127 7/20 0.39
PGR P06401 1/20 0.37
MAPT P10636 5/20 0.36
ATM Q13315 3/20 0.36
MAOB P27338 2/20 0.36
USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065605 0.93 MEN1 (0.43) KMT2AMEN1NPC1POLBRAB9A
SCHEMBL13065622 0.93 MEN1 (0.43) KMT2AMEN1NPC1POLBRAB9A
SCHEMBL13065591 0.93 MEN1 (0.49) KMT2AMEN1NPC1POLBRAB9A
SCHEMBL13065598 0.92 MEN1 (0.43) KMT2AMEN1NPC1POLBRAB9A
SCHEMBL13065623 0.90 MEN1 (0.41) KMT2AMEN1NPC1POLBRAB9A
SCHEMBL13065586 0.90 SCP2 (0.44) KMT2AMEN1NPC1POLBRAB9A
SCHEMBL13065599 0.89 MEN1 (0.41) KMT2AMEN1NPC1POLBRAB9A
SCHEMBL13065624 0.88 DHODH (0.42) KMT2AMEN1NPC1POLBRAB9A
SCHEMBL13065603 0.84 MAPT (0.42) KMT2AMEN1NPC1POLBRAB9A
SCHEMBL13065607 0.83 SLC16A3 (0.36) KMT2AMEN1NPC1POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 KMT2A 4381/4885MEN1 3364/4885NPC1 2196/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 KMT2A 4381/4885MEN1 3364/4885NPC1 2196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.